# A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in Treating COVID-19.

> **NCT06085924** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 8252912 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** SoC
- **OTHER:** Disease description

## Key facts

- **NCT ID:** NCT06085924
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-07
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 8252912 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06085924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06085924, "A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in Treating COVID-19.". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06085924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*